<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="the review (Fig. 1). The 26 CMGs were produced in" exact="Denmark" post="(n = 2), France (n = 2), Germany (n = 2), Ireland (n = 1), the Netherlands"/>
 <result pre="(Fig. 1). The 26 CMGs were produced in Denmark (n = 2)," exact="France" post="(n = 2), Germany (n = 2), Ireland (n = 1), the Netherlands (n = 1), Norway"/>
 <result pre="The 26 CMGs were produced in Denmark (n = 2), France (n = 2)," exact="Germany" post="(n = 2), Ireland (n = 1), the Netherlands (n = 1), Norway (n = 1), Scotland"/>
 <result pre="CMGs were produced in Denmark (n = 2), France (n = 2), Germany (n = 2)," exact="Ireland" post="(n = 1), the Netherlands (n = 1), Norway (n = 1), Scotland (n = 1), Spain"/>
 <result pre="in Denmark (n = 2), France (n = 2), Germany (n = 2), Ireland (n = 1), the" exact="Netherlands" post="(n = 1), Norway (n = 1), Scotland (n = 1), Spain (n = 3), the UK"/>
 <result pre="(n = 2), France (n = 2), Germany (n = 2), Ireland (n = 1), the Netherlands (n = 1)," exact="Norway" post="(n = 1), Scotland (n = 1), Spain (n = 3), the UK (n = 6), Europe"/>
 <result pre="(n = 2), Ireland (n = 1), the Netherlands (n = 1), Norway (n = 1), Scotland (n = 1)," exact="Spain" post="(n = 3), the UK (n = 6), Europe (n = 3), the USA (n = 3)"/>
 <result pre="varying from 10 to more than 14 days. A CMG from" exact="France" post="(2017) recommended the addition of amoxicillin in adults to"/>
 <result pre="L. monocytogenes N **,^ Yes^ up to 4 h post-antibiotics  DSI" exact="Denmark" post="A A if risk of L. monocytogenes Yes  SPILF"/>
 <result pre="Denmark A A if risk of L. monocytogenes Yes  SPILF" exact="France" post="P, A P, A if suspected L. monocytogenes° If"/>
 <result pre="if suspected L. monocytogenes° If S. pneumoniae Yes″  DGN: BM" exact="Germany" post="A A A** Yes  HPSC Ireland P &amp;gt; 2 m, A"/>
 <result pre="pneumoniae Yes″  DGN: BM Germany A A A** Yes  HPSC" exact="Ireland" post="P &amp;gt; 2 m, A N, P &amp;lt; 2 months N, P &amp;lt; 2 months"/>
 <result pre="N, P &amp;lt; 2 months **,^ Yes up to 24 h post-antibiotics  NVN" exact="Netherlands" post="P, A N, A Yes  MHSSE# Spain P Yes"/>
 <result pre="24 h post-antibiotics  NVN Netherlands P, A N, A Yes  MHSSE#" exact="Spain" post="P Yes  NICE UK P &amp;gt; 3 m N, P &amp;lt; 3 months"/>
 <result pre="&amp;gt; 50 years N P, A P^, infants if Hib, A  AEPED" exact="Spain" post="P N, P ≤ 3 months **,^ Yes  MSF Global P"/>
 <result pre="&amp;gt; 3 m, A N, P ≤ 3 months N, P ≤ 3 months Yes^  NNF" exact="Norway" post="NS NS Yes The table shows empirical treatment recommendations"/>
 <result pre="more than 20% in Slovakia, Bulgaria, France, Spain, Iceland, Poland," exact="Malta" post="and Romania [47]. The variations in recommendations seen between"/>
 <result pre="20% in Slovakia, Bulgaria, France, Spain, Iceland, Poland, Malta and" exact="Romania" post="[47]. The variations in recommendations seen between CMGs produced"/>
 <result pre="TBEV Tick-borne encephalitis virus TRIP Turning research into practice UK" exact="United Kingdom" post="UKJSS UK Joint Specialist Societies VZV Varicella-zoster virus WNV"/>
</results>
